- Home
- BRLS vs PROK Comparison
BRLS vs PROK Comparison
Compare BRLS & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLS
- PROK
- Stock Information
- Founded
- BRLS 2019
- PROK 2015
- Country
- BRLS Canada
- PROK United States
- Employees
- BRLS N/A
- PROK N/A
- Industry
- BRLS
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRLS
- PROK Health Care
- Exchange
- BRLS NYSE
- PROK Nasdaq
- Market Cap
- BRLS 130.4M
- PROK 129.5M
- IPO Year
- BRLS N/A
- PROK N/A
- Fundamental
- Price
- BRLS $4.75
- PROK $0.71
- Analyst Decision
- BRLS
- PROK Buy
- Analyst Count
- BRLS 0
- PROK 3
- Target Price
- BRLS N/A
- PROK $4.50
- AVG Volume (30 Days)
- BRLS 142.8K
- PROK 606.0K
- Earning Date
- BRLS 08-13-2025
- PROK 08-08-2025
- Dividend Yield
- BRLS N/A
- PROK N/A
- EPS Growth
- BRLS N/A
- PROK N/A
- EPS
- BRLS N/A
- PROK N/A
- Revenue
- BRLS $26,619,131.00
- PROK $306,000.00
- Revenue This Year
- BRLS N/A
- PROK $54.34
- Revenue Next Year
- BRLS N/A
- PROK N/A
- P/E Ratio
- BRLS N/A
- PROK N/A
- Revenue Growth
- BRLS N/A
- PROK N/A
- 52 Week Low
- BRLS $3.00
- PROK $0.46
- 52 Week High
- BRLS $9.47
- PROK $2.75
- Technical
- Relative Strength Index (RSI)
- BRLS 48.52
- PROK 44.48
- Support Level
- BRLS $4.45
- PROK $0.69
- Resistance Level
- BRLS $6.26
- PROK $1.02
- Average True Range (ATR)
- BRLS 0.93
- PROK 0.11
- MACD
- BRLS 0.10
- PROK -0.01
- Stochastic Oscillator
- BRLS 36.64
- PROK 13.58
About BRLS BOREALIS FOODS INC
Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.